R.E.B.E.L.EM - April 4, 2016 - Posted by Salim Rezaie
"Welcome back to the April 2016 edition of REBELCast. For this episode I was lucky enough to get Scott Weingart on the show to talk to us about all things Apneic Oxygenation (ApOx). ApOx is a concept that has been around for some time in the operating room literature, but only recently been gaining acceptance in the ED, especially after the publication of this concept by Scott and Richard Levitan in the Annals of Emergency Medicine in 2011. Many nay sayers will argue that the OR studies were in controlled settings with elective surgical patients who were not in critical condition. The believers would argue that ApOx makes sense, its low cost, and low complexity. To date there has been no randomized controlled trials (RCTs) on ApOx in the ED. There has been one ICU Trial (i.e. The FELLOW Trial) and an even more recent observational trial in the ED that have been published on the topic of ApOx. So the question remains: Is Apneic Oxygenation Overhyped?"
For More on This Topic Checkout:
- Scott Weingart on EMCrit: Podcast 158 – The FELLOW Trial on Apneic Oxygenation in ICU Patients
- Rory Spiegel on EMCrit: More on the FELLOW Trial
- Scott Weingart on EMCrit: Apneic CPAP Recruitment Demonstration by George Kovacs
- Salim Rezaie on REBEL EM: Preoxygenation and Apneic Oxygenation
- Salim Rezaie on REBEL EM: The FELLOW Trial: An End to Apneic Oxygenation?
- Salim Rezaie on REBEL EM: Should we be Using Apneic Oxygenation (ApOx) in the ED?